Big Chemical Encyclopedia

Chemical substances, components, reactions, process design ...

Articles Figures Tables About

Drug-induced

M Wilson, J DeRisi, HH Kristensen, P Imboden, S Rane, PO Brown, GK Schoolmk. Exploring drug-induced alterations m gene expression m Mycobacterium tuberculosis by microairay hybridization. Proc Natl Acad Sci USA 96 12833-12838, 1999. [Pg.348]

Rare cases of hemolytic anemia, including fatalities, have been reported with the administration of the cephalosporins. The patient should be monitored for anemia If a patient experiences anemia within 2 to 3 weeks after the start of cephalosporin therapy, drug-induced anemia should be considered. If hemolytic anemia is suspected, the primary health care provider will discontinue the drug therapy. The patient may require blood transfusions to correct tire anemia. Frequent hematological studies may be required. [Pg.79]

Doxapram is used to treat drug-induced respiratory depression and to temporarily treat respiratory depression in patients with chronic pulmonary disease This drug also may be used during the postanesthesia period when respiratory depression is caused by anesthesia It also is used to stimulate deep breathingin patients after anesthesia... [Pg.247]

Q Impaired Verbal Communication related to drug-induced extrapyramidal effects (eg, dystonia)... [Pg.300]

Decreased Cardiac Output related to adverse drug reactions (drug-induced arrhythmias)... [Pg.374]

Open-angle glaucoma, secondary glaucoma, preoperatively to lower Intraocular pressure (IOP), edema due to CHF, drug-induced edema, centrencephalic epilepsy Glaucoma... [Pg.444]

Other Inflammatory Muscle Disorders Endocrine Myopathies Thyroid Disorders Adrenal Disorders Pituitary Disorders Parathyroid Disorders Pancreatic Disorders Drug-Induced and Toxic Myopathies Management of Muscle Disease... [Pg.282]

To cover these various disorders in an orderly and comprehensive manner, the following sections are devoted, respectively, to the muscular dystrophies the congenital myopathies the metabolic myopathies the myotonias, periodic paralyses, and malignant hyperpyrexia the neurogenic disorders the inflammatory muscle disorders the endocrine myopathies and the drug-induced and toxic myopathies. [Pg.284]

Drug-induced and toxic myopathies are probably more common than is generally realized, but the distinctive feature of these conditions is that muscle damage is usually resolved rapidly once the causal agent is removed. The specific causes of damage vary considerably as does the presence of pain and discomfort. [Pg.343]

Systemic muscle damage, often associated with pain and discomfort, is a well known problem associated with specific drugs such as epsilon amino caproic acid (EACA), clofibrate, emetine, vincristine, chloroquine, D-penicillamine, and anabolic steroids. Notes on each of these drugs follow, but for a detailed discussion of drug-induced muscle damage refer to Argov and Mastaglia (1988) and Harris and Blain (1990). [Pg.343]

Corticosteroids a chronic painless myopathy associated with the long-term use of corticosteroids is a particularly common example of drug-induced muscle disorder. It is almost certain that mild cases are overlooked because steroids are so frequently used to treat inflammatory myopathies such as polymyositis. Fluorinated steroids are particularly frequently implicated, and the incidence of drug-induced muscle disease is dose and time-related. The presence of muscle weakness can even complicate topical steroid therapy. Corticosteroid-induced myopathy is mediated via intramuscular cytosolic steroid receptors. The steroid-receptor complexes inhibit protein synthesis and interfere with oxidative phosphorylation. The myopathy is associated with vacuolar changes in muscle, and the accumulation of cytoplasmic glycogen and mitochondrial aggregations. [Pg.344]

Argov, Z., Mastaglia, F.L. (1988). Drug-induced neuromuscular disorders in man. In Disorders of Voluntary Muscle (Walton, J.N., ed.), pp. 981-1014, Churchill-Livingstone, Edinburgh. [Pg.353]

Beere, H.M., Morimoto, R.I., Hickman, J.A. (1993). Investigations of mechanisms of drug-induced changes in gene expression N methylformamide-induced changes in synthesis of the M(r) 72,000 constitutive heat shock protein during commitment of HL-60 cells to granulocyte differentiation. Cancer Res. 53, 3034—3039. [Pg.451]

Manzerra, P. Brown, I.R. (1990). Time course of induction of a heat shock gene (hsp70) in the rabbit cerebellum after LSD in vivo Involvement of drug-induced hyperthermia. Neurochen. Res. 15, 53-59. [Pg.457]

Two main apoptotic pathways have been identified in mammalian cells the extrinsic pathway that is activated by the binding of ligands to cell-surface death receptors, and the intrinsic pathway that involves the mitochondrial release of cytochrome cP The activation of extrinsic and intrinsic apoptotic pathways promotes the cleavage into the active form of the pro-caspase-8 and pro-caspase-9, respectively, that mainly determine the activation of effector caspase-3. ° The intrinsic pathway is the main apoptotic pathway activated by chemotherapeutic drugs, while the cytotoxic drug-induced activation of the extrinsic pathway is a more controversial issue. ... [Pg.359]

Deres K, Schroder CH, Paessens A, Goldmann S, Hacker HJ, Weber O, Kramer T, Niewohner U, Pleiss U, Stoltefuss J et al. (2003) Inhibition of hepatitis B virus replication by drug-induced depletion of nucleocapsids. Science 299 893-896 Ehon GB, Furman PA, Fyfe JA, de Miranda P, Beauchamp L, Schaeffer HJ (1977) Selectivity of action of an antiherpetic agent, 9-(2-hydroxy ethoxy methyl) guanine, Proc Natl Acad Sci USA 74 5716-5720... [Pg.22]


See other pages where Drug-induced is mentioned: [Pg.137]    [Pg.34]    [Pg.59]    [Pg.74]    [Pg.114]    [Pg.192]    [Pg.343]    [Pg.406]    [Pg.443]    [Pg.444]    [Pg.485]    [Pg.583]    [Pg.704]    [Pg.994]    [Pg.1274]    [Pg.225]    [Pg.248]    [Pg.266]    [Pg.266]    [Pg.268]    [Pg.398]    [Pg.447]    [Pg.343]    [Pg.343]    [Pg.345]    [Pg.431]    [Pg.123]    [Pg.156]    [Pg.189]    [Pg.220]    [Pg.235]    [Pg.346]    [Pg.168]    [Pg.171]   
See also in sourсe #XX -- [ Pg.186 , Pg.192 ]




SEARCH



Abortion, drug-induced

Acute tubular necrosis drug-induced

Adrenal insufficiency drug-induced

Agranulocytosis, drug-induced

Akathisia drug-induced

Allergic reactions drug induced

Amnesia-inducing drugs

Anaphylaxis (anaphylactic reactions drug-induced

Anemia aplastic, drug-induced

Anemia drug-induced

Angioedema drug-induced

Antiepileptic drugs valproate-induced liver

Antinuclear antibodies, drug-induced

Antinuclear antibodies, drug-induced autoimmunity

Anxiety drug-induced

Aplastic anemia, drug-induced treatment

Apnea drug-induced

Arrhythmias drug-induced

Arrhythmias, cardiac drug-induced

Asthma drug-induced

Autoantibodies drug-induced

Autoimmune disorder drug-induced

Autoimmune drug-induced hepatotoxicity

Autoimmunity, drug-induced

Behavior drug-induced

Behavior drug-induced cognitive impairment

Behaviour drug-induced

Biomarkers drug-induced vascular injury

Biomarkers skeletal muscle injury, drug-induced

Birth defects drug-induced

Blood disorders drug-induced

Bronchospasm drug-induced

Bullous pemphigoid, drug-induced

Cardiac arrest, drug-induced

Cardiovascular system drug-induced effects

Cholestasis drug-induced hepatotoxicity

Cholestasis, drug-induced

Chronic hepatitis drug-induced

Cirrhosis drug-induced

Constipation drug-induced

Cough drug-induced

Critical care drug-induced

Cushing syndrome, drug-induced

Cytokines drug-induced autoimmunity

Deficiency drug-induced

Depression drug-induced

Dermatitis drug-induced

Dermatological reactions drug-induced

Diabetes insipidus drug-induced

Diabetes mellitus drug-induced

Diarrhea drug-induced

Disease drug-induced

Drug Induced Liver Injury Models

Drug induced liver injury network

Drug induced liver injury network DILIN)

Drug induced sleep

Drug induced thrombocytopenia

Drug-Induced Effects on Other ECG Parameters

Drug-Induced Folate Deficiency

Drug-Induced Pancreatic Exocrine Toxicity in Humans

Drug-Induced Proarrhythmic Effects in Dogs with Chronic AV Ablation

Drug-Induced Rape

Drug-Induced Rape Prevention and

Drug-Induced Rape Prevention and Punish

Drug-Induced Rape Prevention and Punishment

Drug-Induced Rape Prevention and Punishment Act

Drug-Induced Reactions During Anesthesia

Drug-Induced Vitamin B6 Deficiency

Drug-induced AP

Drug-induced Parkinsonism

Drug-induced QT interval prolongation

Drug-induced amnesia

Drug-induced apoptosis

Drug-induced autoimmune disease

Drug-induced autoimmune disease autoimmunity

Drug-induced autoimmune disease mechanisms

Drug-induced cognitive impairment

Drug-induced cutaneous reactions

Drug-induced delayed reactions

Drug-induced delayed-type cutaneous hypersensitivity

Drug-induced delayed-type cutaneous hypersensitivity reactions

Drug-induced diabetes

Drug-induced disorder

Drug-induced disorders cholestasis

Drug-induced disorders hepatic

Drug-induced dyskinesia

Drug-induced fever

Drug-induced gastric disease

Drug-induced gene expression, phospholipidosis

Drug-induced haploinsufficiency

Drug-induced hematological disorders

Drug-induced hepatitis

Drug-induced hepatotoxicity

Drug-induced highs

Drug-induced histamine release

Drug-induced hypersensitivity syndrome

Drug-induced illness

Drug-induced illness causes

Drug-induced illness liver

Drug-induced immune hemolytic anemia

Drug-induced kidney injury

Drug-induced kidney injury biomarker

Drug-induced kidney injury clusterin

Drug-induced kidney injury detection

Drug-induced liver damag

Drug-induced liver injury

Drug-induced liver injury acetaminophen

Drug-induced liver injury alanine aminotransferase

Drug-induced liver injury alcohol

Drug-induced liver injury animal models

Drug-induced liver injury biomarkers

Drug-induced liver injury cancer

Drug-induced liver injury cholestasis

Drug-induced liver injury drugs

Drug-induced liver injury idiosyncratic

Drug-induced liver injury immune reactions

Drug-induced liver injury impairment

Drug-induced liver injury incidence

Drug-induced liver injury microRNA

Drug-induced liver injury predictable

Drug-induced liver injury safety assessment

Drug-induced liver injury types

Drug-induced lung disease

Drug-induced lupus

Drug-induced lupus-like reactions

Drug-induced mitochondrial dysfunction

Drug-induced nephrotoxicity mechanism

Drug-induced nephrotoxicity mechanism injury

Drug-induced pancreatitis

Drug-induced protein changes

Drug-induced psychosis

Drug-induced pulmonary disease

Drug-induced renal disease

Drug-induced risk

Drug-induced serum sickness

Drug-induced side effects

Drug-induced side effects studies

Drug-induced skeletal muscle injury

Drug-induced sleep disruption

Drug-induced thrombotic microangiopathy

Drug-induced toxicity

Drug-induced vascular injury

Drug-metabolizing enzymes, inducers

Drugs drug-induced side effects

Drugs that Induce the Mitochondrial Permeability Transition Pore (MPT)

Dyskinesias, drug-induced therapy

Dysphoria drug-induced

Dystonias, drug-induced

Early Studies on Opioid Drug-Induced Release of Histamine

Edema drug induced

Effusions, pleural, drug-induced

Enzyme-inducing antiepileptic drugs

Erectile dysfunction drug-induced

Erythema multiforme drug-induced

Exanthema, drug-induced

Fibrosis drug-induced

Fibrosis pleural, drug-induced

Fixation Test for Drug-Induced Thrombocytopenia

Glaucoma drug-induced

Glomerular disease drug-induced

Glomerulonephritis drug-induced

Granulocytopenia, drug-induced

Growth hormone drug-induced

Haemolysis, drug-induced

Hair loss drug-induced

Heart failure drug-induced

Hematologic disorders drug-induced

Hemolysis, drug induced

Hemolytic anemia drug-induced

Hepatic disease drug-induced

Hepatocellular failure, drug-induce

Hirsutism drug-induced

Histamine opioid drug-induced release

Hypercalcemia drug-induced

Hyperglycemia, drug-induced

Hyperkalaemia drug-induced

Hyperkalemia drug-induced

Hyperlipidemia drug-induced

Hyperprolactinemia drug-induced

Hypertension drug induced

Hyperuricemia drug-induced

Hypocalcemia drug-induced

Hypoglycemia, drug-induced

Hypokalemia drug-induced

Hypomagnesemia drug-induced

Hypothermia, drug-induced

Hypothyroidism drug-induced

Hypoxia-Induced Drug Release or Exposure of Positive Charge

INDEX drug-induced

Immune complex-mediated drug-induced

Incidences of Drug- and Other Agent-Induced Anaphylaxis During Anesthesia

Induced Anticancer Drug Resistance in Cell Culture

Induced Folding The Bete Noire of Drug Design

Inducible pluripotent stem cells drug-induced liver injury

Infiltrates, pulmonary, drug-induced

Injury drug-induced

Insomnia drug-induced

Integrating Novel Imaging Technologies to Investigate Drug-Induced Kidney Toxicity

Interstitial nephritis drug-induced

Intracranial hypertension, drug-induced

Iodine-induced hyperthyroidism antithyroid drugs

Jaundice cholestatic, drug-induced

Jaundice, drug-induced

Kidney disease, drug-induced

Kidney disease, drug-induced prevention

Liver cancer, drug-induced

Liver disease drug-induced

Liver drug-induced

Liver drug-induced disease/damage

Lung drug-induced

Lupus erythematosus drug-induced

Lupus syndrome drug-induced

Lymphoid disease, drug-induced

Maculopapular eruptions, drug-induced

Mania drug-induced

Manic symptoms, drug-induced

Megaloblastic anemia drug-induced

Membranous nephropathy drug-induced

Metabolic alkalosis drug-induced

Miosis drug-induced

Mydriasis drug-induced

Myopathies drug-induced

National Registry of Drug-Induced

National Registry of Drug-Induced Ocular Side Effects

Nausea drug-induced

Nephrolithiasis drug-induced

Nephropathy drug-induced

Nephrotoxicity drug-induced

Neuroleptic drugs drug-induced)

Neutropenia drug-induced

Neutropenia-inducing drugs

Nonsteroidal anti-inflammatory drug-induced ulcers

Osteomalacia drug-induced

Osteoporosis drug induced

Ototoxicity, drug-induced

Parkinson’s disease drug-induced

Pemphigoid drug-induced

Pemphigus, drug-induced

Peptic ulcer disease drug-induced

Phospholipidosis drug-induced

Photoallergic reactions, drug-induced

Photosensitivity reactions, drug-induced

Phototoxicity, drug-induced

Pigmentation, drug-induced

Pneumonitis, drug-induced

Post-Receptorome Screening Data Implicate 5-HT2b Receptors in Drug-Induced VHD and PH

Preclinical Safety Assessment of Drug Candidate-Induced Pancreatic Toxicity From an Applied Perspective

Prolactin antipsychotic drug-induced

Prostate drug-induced

Pruritus drug-induced

Psoriasis drug-induced

Psychiatric disorders drug induced

Pulmonary edema drug-induced

Pulmonary eosinophilia, drug-induced

Pulmonary fibrosis drug-induced

Pulmonary hypertension drug-induced

Pulmonary toxicity, drug-induced

Purpura drug-induced

Renal failure drug-induced

Renal failure, acute drug-induced

Renal tubular obstruction, drug-induced

Respiratory depression, drug-induced

Respiratory depression, drug-induced opioids

Respiratory disorders drug-induced

Rhabdomyolysis, drug-induced

Rhinitis drug-induced

Rickets drug-induced

Sedation, drug-induced

Seizure drug-induced

Significance of Drug-Induced QT Prolongation

Skin disorders drug-induced

Sleep disorders drug-induced

Specific Organ Damage Induced by Cardiovascular Drugs

Steatohepatitis, drug-induced

Stem cells drug-induced liver injury

Systemic lupus erythematosus drug-induced

Tachycardia drug-induced

Tamoxifen-induced drug resistance

Teratogenicity drug-induced

Thrombocytopenia cytotoxic drug-induced

Thyroid disorders drug-induced

Thyrotoxicosis drug-induced

Toxicity drug-induced psychosis

Toxicity liver, drug-induced

Tubulointerstitial disease drug-induced

Urinary incontinence drug-induced

Urticaria drug-induced

Using Drugs to Induce Altered States

Uveitis drug-induced

Vascular disorders, drug-induced

Vasculitis, drug-induced

Veno-occlusive disease drug-induced

Vitamin antiepileptic drug-induced

Vitamin drug induced

Vomiting drug-induced

Weight gain drug-induced

© 2024 chempedia.info